Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | FLT3 | P36888 | 2/20 | 0.40 |
| ▸ | NT5E | P21589 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.35 |
| ▸ | KCNMA1 | Q12791 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19848242 | 0.87 | ALDH1A1 (0.49) | ALDH1A1FLT3KDM4ENPC1L3MBTL1 | |
| SCHEMBL19848719 | 0.85 | KDM4E (0.53) | ALDH1A1NT5EKDM4ENPC1L3MBTL1 | |
| SCHEMBL19848435 | 0.81 | ALDH1A1 (0.46) | ALDH1A1KDM4ENPC1L3MBTL1RAB9A | |
| SCHEMBL22567102 | 0.80 | ALDH1A1 (0.51) | ALDH1A1NT5EKDM4ENPC1L3MBTL1 | |
| SCHEMBL19848336 | 0.80 | NPC1 (0.55) | ALDH1A1NT5EKDM4ENPC1L3MBTL1 | |
| SCHEMBL19848740 | 0.80 | ALDH1A1 (0.45) | ALDH1A1FLT3NT5EKDM4ENPC1 | |
| SCHEMBL19911524 | 0.80 | HDAC3 (0.45) | ALDH1A1NT5EL3MBTL1RAB9AMAPT | |
| SCHEMBL19848720 | 0.78 | NT5E (0.39) | ALDH1A1NT5EKDM4EKMT2ACYP1A2 | |
| SCHEMBL26004845 | 0.77 | NT5E (0.46) | ALDH1A1NT5ENPC1L3MBTL1RAB9A | |
| SCHEMBL19848488 | 0.76 | ALDH1A1 (0.42) | ALDH1A1NT5EKDM4ENPC1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | ALDH1A1 3497/4885FLT3 482/4885NT5E 2513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.